Posted on November 20, 2019 by Sitemaster
There have long been suggestions that men already diagnosed with and receiving treatment for diabetes are at lower risk for a subsequent diagnosis of prostate cancer than non-diabetics. However, a very large, new, epidemiological analysis seems to suggest strongly that this may not be the case at all. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: ant-diabetic, diabetes, medication, Prevention, risk | 3 Comments »
Posted on November 19, 2019 by Sitemaster
A newly published paper by Blayer et al. in in the journal Cancer has stated that,
Worldwide, the incidence of prostate cancer has increased in all groups between ages 15 and 40 years and increased globally at a steady rate averaging 2% per year since 1990.
… READ MORE …
Filed under: Diagnosis, Risk | Tagged: age, Diagnosis, risk, youth | 2 Comments »
Posted on November 15, 2019 by Sitemaster
Over the past month there have been no new postings to this web site. Your sitemaster apologizes for this hiatus.
The reasons are complex and include the sitemaster’s personal health status (nothing really serious but distinctly debilitating) and other business and personal pressures.
The current goal is to start to get things back on track as on Monday, November 18, so please be patient with us for just a couple more days.
Filed under: Uncategorized | 11 Comments »
Posted on October 2, 2019 by Sitemaster
It is with great regret that we must report the demise — last Saturday — of Dr. Gerald (“Gerry”) Chodak — formerly a professor of urology at the University of Chicago Pritzker School of Medicine. … READ MORE …
Filed under: Uncategorized | Tagged: Chodak, death, Gerald | 7 Comments »
Posted on October 1, 2019 by Sitemaster
Although at least three randomized clinical trials have told us that adjuvant radiation after prostatectomy often affords better results than just taking a “wait-and-see” approach, … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, early, port-surgery, radiation, salvage | Leave a comment »
Posted on October 1, 2019 by Sitemaster
From a report presented by Hussain yesterday at the annual meeting of the European Society for Medical Oncology (ESMO) we gained detailed insight into the results of the PROfound trial of olaparib (Lynparza), which had been said to be positive last August. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, gene, Lynparza, mCRPC, metastatic, mutation, olaparib | 3 Comments »
Posted on September 27, 2019 by Sitemaster
In posting the following commentary, we wish to be VERY clear that, at this time, there is no definitive evidence that there is a causal relationship between male infertility and risk for prostate cancer, but this does appear to be a POSSIBILITY. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: assistaed, Diagnosis, fertility, male, reproduction, risk | Leave a comment »